Dr. Matthew Ryan Kearney, MD

  • Bronxville, NY
  • Hematologist and oncologist
NPI1023470788PAC ID3678860442
Medicare services, 2024
417
Medicare patients, 2024
227
Part D claims, 2024
379
Publications
9
MIPS score, 2024
100
Practice address
55 Palmer Ave, Bronxville, NY 10708
Practice phone
Call (914) 787-5008
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

NewYork-Presbyterian Westchester

Mammography / Breast Imaging Center · Bronxville, New York

See all 5 affiliations

Find Dr. Kearney's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Matthew Ryan Kearney is a hematologist and oncologist in Bronxville, New York

Dr. Kearney practices at NewYork-Presbyterian Westchester in Bronxville, New York.

Dr. Kearney's NPI, 1023470788, was assigned on March 22, 2016. Dr. Kearney graduated from Drexel University College of Medicine in 2016. Dr. Kearney holds New York license 297600.

NPI and contact details
Medicare PAC ID
3678860442
NPI enumeration date
March 22, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(914) 787-5008
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
36
Medical school graduation
2016

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Matthew Ryan Kearney practices at NewYork-Presbyterian Westchester in Bronxville, New York

Dr. Kearney's primary practice is NewYork-Presbyterian Westchester, at 55 Palmer Ave, Bronxville, NY 10708. The practice phone is (914) 787-5008.

  • NewYork-Presbyterian Westchester
    55 Palmer Ave, Bronxville, NY 10708Phone(914) 787-5008

Source: Dmand AI Affiliation Data

Dr. Matthew Ryan Kearney is affiliated with 4 sites of care and 1 medical group

Dr. Kearney's primary practice is NewYork-Presbyterian Westchester in Bronxville, New York. Dr. Kearney is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group Westchester. Dmand AI also links Dr. Kearney to 1 more group practice or clinic and 1 home health agency, each named with a free account.

See all 5 affiliations for Dr. Kearney

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Matthew Ryan Kearney's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kearney practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
NewYork-Presbyterian WestchesterAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Kearney practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Matthew Ryan Kearney is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Kearney's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kearney is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kearney's licenses on file in 3 states: New York, Kansas and Missouri.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 297600 · taxonomy 207RH0003X
  • Kansas licenseLicense 0445861
  • Missouri licenseLicense 2022013731

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and lymphoma among the conditions Dr. Kearney treats.

Hematologists and oncologists near Dr. Kearney

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

996hematologists and oncologists in New York
5hematologists and oncologists in Bronxville

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Matthew Ryan Kearney billed Medicare for 417 services in 2024

CMS data shows 417 Medicare services from Dr. Kearney across 5 procedure codes in 2024, for 227 Medicare patients. Medicare paid $36,743 for them.

Medicare services, 2024417
Medicare patients227
Paid by Medicare$36,743
Procedure codes5

Dr. Kearney's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6162024: 39736%
Other services
2023: 02024: 20

Where Dr. Kearney's Medicare services took place, 2024

  • In an office164%
  • In a facility40196%

Dr. Kearney compared with the New York median for hematologists and oncologists, 2024

  • Dr. Kearney
  • New York median
Medicare services
417vs 66838% below
Medicare patients
227vs 2108% above
Part D claims
209vs 25819% below

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Kearney's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kearney

Need commercial claims for Dr. Kearney?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kearney and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Matthew Ryan Kearney treated 227 Medicare patients in 2024, average age 78

CMS counts 227 Medicare patients who saw Dr. Kearney in 2024. The largest group is 75 to 84, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kearney's median patient age at 72, with 66% women.

Medicare patients, 2024227
Average age78
Average risk score2.15
Also on Medicaid19%

Dr. Kearney's Medicare patients by age, 2024

Dr. Kearney's Medicare patients by sex, 2024

  • Women14062%
  • Men8738%

Chronic conditions among Dr. Kearney's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis53%
  4. Diabetes41%
  5. Ischemic heart disease35%
  6. Anxiety32%
  7. Chronic kidney disease30%
  8. Cancer28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kearney's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women66%
  • Men32%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Matthew Ryan Kearney wrote 379 Medicare Part D claims in 2024

In 2024, Dr. Kearney wrote 379 Medicare Part D claims for 111 patients. 82% of them were for generic drugs. CMS names the drug for 209 of them, across 11 drugs with 11 or more claims each, at $299,914 in total drug cost. In 2023, CMS named 586 claims across 22 drugs.

Part D claims, 2024379
Drugs named by CMS11
Total drug cost$299,914
Part D patients111

Dr. Kearney's Part D claims by kind of drug, 2024

  • Generic312 claims82%
  • Brand-name and other67 claims18%

Dr. Kearney's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kearney's Part D claims, 2024

  • Opioids4%16 of 379 claims
  • Antibiotics7%27 of 379 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5862024: 20964%

Drugs named by CMS: 11 in 2024, 22 in 2023.

See all prescribing by Dr. Kearney

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Matthew Ryan Kearney scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kearney for performance year 2024, reported through an alternative payment model (APM). Dr. Kearney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kearney as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Kearney's MIPS scores, performance year 2024

  • 100of 100Final score
  • 85.3of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Kearney by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Matthew Ryan Kearney has 9 publications on record

Dmand AI links 9 papers to Dr. Kearney, published from 2018 to 2022. 2021 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Receptor, ErbB-2. Dr. Kearney has published most often in Breast Cancer Res Treat. Dr. Kearney's most frequent co-authors are Kevin M. Kalinsky, MD, Thomas Grier Deloughery, MD and Melissa K. Accordino.

Papers9
Years published2018 to 2022

Dr. Kearney's papers by year, 2018 to 2022

Topics Dr. Kearney writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Receptor, ErbB-2
  • Biomarkers, Tumor
  • Hormones
  • Liver Neoplasms
  • Neoadjuvant Therapy

Dr. Kearney's most frequent co-authors

Recent publications by Dr. Kearney

See all 9 publications and co-authors

See who Dr. Kearney researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kearney works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Matthew Ryan Kearney received $326 in industry payments from 2019 to 2022

CMS Open Payments shows 3 general payments to Dr. Kearney from 3 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 77% of the total. Abiomed paid the most, $125.

General payments to Dr. Kearney by program year, 2019 to 2022

General payments to Dr. Kearney by kind, 2019 to 2022

$326in total
  • Food and beverage$25077%
  • Education$7623%

Companies that paid Dr. Kearney the most, 2019 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Kearney

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Matthew Ryan Kearney graduated from Drexel University College of Medicine

Dr. Kearney graduated from Drexel University College of Medicine in 2016.

  1. Medical schoolDrexel University College of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Matthew Ryan Kearney accepts plans from 15 insurance carriers

Dr. Kearney is in network with 15 carriers, including Elevance, Aetna and MVP Health Care. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Plan types Dr. Kearney accepts, by number of carriers

  1. PPO9
  2. HMO8
  3. Medicare6
  4. POS6
  5. EPO5
  6. Medicaid4

Source: Dmand AI Insurance Network Data

Sources for Dr. Matthew Ryan Kearney's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Matthew Ryan Kearney

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Matthew Ryan Kearney's NPI number?

Dr. Matthew Ryan Kearney's NPI number is 1023470788. It was assigned on March 22, 2016, and it is active in the NPI Registry.

What kind of doctor is Dr. Matthew Ryan Kearney?

Dr. Matthew Ryan Kearney is a hematologist and oncologist in Bronxville, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Matthew Ryan Kearney practice?

Dr. Kearney practices at 55 Palmer Ave, Bronxville, NY 10708. Dr. Kearney's primary practice is NewYork-Presbyterian Westchester in Bronxville, New York. Dmand AI also links Dr. Kearney to 1 group practice or clinic and 1 home health agency.

What is Dr. Matthew Ryan Kearney's office phone number?

The practice phone on file for Dr. Kearney is (914) 787-5008.

What is Dr. Matthew Ryan Kearney's medical license number?

Dr. Kearney holds New York license 297600, one of the licenses on file in 3 states.

Which states has Dr. Matthew Ryan Kearney been licensed in?

Dmand AI has state licenses on file for Dr. Kearney in New York, Kansas and Missouri.

Which hospitals is Dr. Matthew Ryan Kearney affiliated with?

Dr. Kearney is affiliated with NewYork-Presbyterian/Weill Cornell Medical Center.

What medical group is Dr. Matthew Ryan Kearney part of?

Dr. Kearney is linked to NewYork-Presbyterian Medical Group Westchester.

Does Dr. Matthew Ryan Kearney accept Medicare?

Yes. CMS data shows Dr. Kearney billed Medicare for 417 services in 2024, and Dr. Kearney accepts Medicare assignment.

Does Dr. Matthew Ryan Kearney offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Kearney as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Matthew Ryan Kearney's MIPS score?

Dr. Kearney's MIPS final score for performance year 2024 is 100 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Matthew Ryan Kearney see?

CMS counts 227 Medicare patients who saw Dr. Kearney in 2024, with an average age of 78.

Is Dr. Matthew Ryan Kearney board certified?

Yes. Dr. Kearney is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Matthew Ryan Kearney bill to Medicare?

In 2024, Dr. Kearney's most billed Medicare services were office visit, established patient (99214), office visit, new patient (99204) and hospital inpatient care (99232).

Where did Dr. Matthew Ryan Kearney go to medical school?

Dr. Kearney graduated from Drexel University College of Medicine in 2016.

What drugs does Dr. Matthew Ryan Kearney prescribe most?

In 2024 Medicare Part D data, Dr. Kearney's most prescribed drugs by claims were Anastrozole, Eliquis and Prednisone.

Has Dr. Matthew Ryan Kearney received payments from drug or device companies?

CMS Open Payments shows $326 in general payments to Dr. Kearney from 3 companies from 2019 to 2022. The largest total came from Abiomed.

How long has Dr. Matthew Ryan Kearney been practicing?

Dr. Kearney graduated from medical school in 2016, 10 years ago.

Does Dr. Matthew Ryan Kearney do research?

Dmand AI links 9 publications to Dr. Kearney, published from 2018 to 2022.

Who does Dr. Matthew Ryan Kearney publish with?

Dr. Kearney's most frequent co-authors are Kevin M. Kalinsky, MD (3 shared papers), Thomas Grier Deloughery, MD (2 shared papers) and Melissa K. Accordino (1 shared paper).

What insurance does Dr. Matthew Ryan Kearney accept?

Dr. Kearney is in network with 15 carriers, including Elevance, Aetna and MVP Health Care. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)